Main Article Content


Bone is an important organ for supports the body that stores reserve of calcium, phosphorus, and other minerals. In fracture conditions where bleeding, soft tissue edema, nerve damage, and blood vessels around the bone damage happen, they can cause the mobilization of these minerals in the surrounding tissue. One of the efforts made in the treatment of these fractures is reconnection, in which it works by filling of bone defect with a matrix and administration of anti-infection. Biomaterial filling in defective bone is thought to accelerate the healing process of bone fracture and prevent osteomyelitis. For this reason, this study evaluates the acceleration of bone fracture healing using natural hydroxyapatite (NHA) bone filler in rabbits with bone defect model. Fracture modeling was performed by surgical technique and drilling of bones with a 4.2 mm diameter to form a defect in the rabbit femur. Bone implant contained bovine hydroxyapatite-gelatin-glutaraldehyde (BHA implant) or bovine hydroxyapatite-gelatin-glutaraldehyde-gentamicin (BHA-GEN implant) that was inserted in bone defects. 27 rabbits were divided into 3 groups: the control group who had bone defect, the bone defect group was given BHA implant and the bone defect group was given BHA-GEN implant. Observation of osteoclast, osteoblast, osteocyte, BALP level, and bone morphological integrity was carried out on the 14th, 28th, and 42nd days after surgery. Histological observation of rabbit femur showed a significant difference on the number of osteoclast, osteoblast and osteocyte in all three groups. The BALP level also showed a significant difference in the group given the natural BHA bone implant compared to the control group on day 14 (p = 0.0361). Based on the result of the X-ray, there was also a better integration of rabbit femur bone in groups with the use of BHA or BHA-GEN bone implant. Thus, it can be concluded that the use of a natural BHA implant can accelerate the process of bone repair in the fracture of rabbit femur. In addition, BHA implants were compatible as a matrix for supporting the bone cell growth.


Bone remodeling fracture natural bovine hydroxyapatite bone alkaline phosphatase

Article Details

How to Cite
Khotib, J., Lasandara, C. S., Samirah, S., & Budiatin, A. S. (2019). Acceleration of Bone Fracture Healing through the Use of Natural Bovine Hydroxyapatite Implant on Bone Defect Animal Model. Folia Medica Indonesiana, 55(3), 176–187.


  1. Askarzadeh K, People F, Moztarzadeh F (2005). Fabrication and characterization of a porous compo-site implant based on gelatin and hydroxyapatite for bone tissue engineering. Iranian Polymer Journal 14, 511-520
  2. Azami M, Tavakol S, Samadikuchaksaraei A, Hashjin SM, Baheiraei N, Kamali M, Nourani MR (2012). A porous hydroxyapatite/gelatin nanocomposite implant for bone tissue repair: In vitro and in vivo evaluation. Journal of Biomaterial Science 23, 2353-2368
  3. Boanini E, Torricelli P, Gazzano M, Giardino R, Bigi A (2008). Alendronate - hydroxyapatite nanocomposites and their interaction with osteoclasts and osteoblast - like cells. J. Biomaterials 29, 790-796
  4. Brunner & Suddarth (1997). Brunner and Suddarth's Journal of Medical-Surgical Nursing . 7th Ed. 6-15.
  5. Budiatin Aniek Setiya, et al (2013). Gentamicin release from bovin-hydroxy-apatite-gelatin implant as a drug and bone filling delivery system. Indonesian Journal of Pharmacy and Pharmaceutical Sciences 1, 10-11
  6. Budiatin AS, Zainuddin M, Khotib J (2014). Biocompatable composite as gentamicin delivery system for osteomyelitis and bone regeneration. International Journal of Pharmacy and Pharmaceutical Sciences 6, 223-226
  7. Capra P, Dorati R, Colonna C, Giovanna B, Pavanetto, F, Genta I, Conti B (2011). A preliminary study on the morphological and release properties of hydroxyapa-tite-alendronate composite materials. Journal of Microencapsulation 28, 395-405
  8. Cattalini JP, Boccaccini AR, Habil Dr.-Ing, Lucangioli S, Mourino V (2012). Bisphosphonate-based strategies for bone tissue engineering and orthopedic implants. Tissue Engineering Part B 18, 5-8
  9. Chang J, Lin K (2015). Structure and properties of hydroxyapatite for biomedical applications. Hap for Biomedical Applications, 3-19
  10. Chao SC, Wang MJ, Pai NS, Yen SK (2015). Preparation and characterization of gelatin-hydroxyapatite composite microspheres for hard tissue repair. Materials Science and Engineering C 57, 113-122
  11. Chen G, Deng C, Li YP (2012). TGF-β and BMP signaling in osteoblast differentiation and bone formation. International Journal of Biological Sciences 8, 272-288
  12. Cottrell JA, Vales FM, Schachter D, Wadsworth S, Gundlapalli R, Kapadia R, O'Connor JP (2010). Osteogenic activity of locally applied small molecule drugs in a rat femur defect model. Journal of Biomedicine and Biotechnology 597641, 1-2
  13. Einhorn TA (2010). Can an anti-fracture agent heal fractures?. Clinical Cases in Minerals and Bone Metabolism 6, 251-253
  14. Einhorn TA, Gerstenfeld LC (2014). Fracture healing: Mechanism and interventions. Nature Reviews Rheumatology, 355-337
  15. Ellis EG, Kathleen B (2007). The role of alkaline phosphatase in mineralization. Curr Opin Orthop 18, 444-448
  16. Ferdiansyah, Rushadi D, Rantam FA, Aulani'am (2010). Regeneration of massive bone defect with bovine hydroxyapatite as mesenchymal stem cells' implants 13, 179-195
  17. Fischer AH, Jacobson KA, Rose J, Zeller R (2008). Hematoxylin and eosin staining of tissue and cell sections. Cold Spring Harbor Protocols 3, 4986-4988
  18. Goes P, Melo MI, Dutra SC, Lima SPA, Lima V (2012). Effect of alendronate on bone - specific alkaline phosphatase on periodontal bone loss in rats. Archives of Oral Biology 57, 1537-1274
  19. Greenblatt MB, Tsi JN, Wein, MN (2017). Bone turnover markers in the diagnosis and monitoring of metabolic bone disease. Clinical Chemistry 63, 464-474
  20. Guyton AC, Hall JE (2007). Medical physiology textbook. 9th Ed. Jakarta, EGC, p 6-7
  21. Hikmawati D, Maulida HN, Putra AP, Budiatin AS and Syahrom A (2019). Synthesis and characterization of nanohydroxyapatite-gelatin composite with streptomy-cin as antituberculosis injectable bone substitute. International Journal of Biomaterials 2019
  22. Kalfas IH (2001). Principles of bone healing. Neurosurg Focus 10, 7-10
  23. Kim, HW, Knowles, JC, Kim HE (2004). Hydroxyapatite and gelatin composite foams processed via novel freeze-drying and crosslinking for use as temporary hard tissue implants. Journal of Biomedical Materials Research - Part A 72, 136-145
  24. Kusrini E, Sontang M (2012). Characterization of X-ray diffraction and electron spin resonance: Effects of sintering time and temperature on bovine hydroxyapatite. Rad Physical and Chem, 118-125
  25. Marsell R, Einhorn TA (2011). The biology of fracture healing. Injury 42, 551-555
  26. Maulida HN, Hikmawati D, Budiatin AS (2015). Injectable bone substitute paste based on hydroxyapatite, gelatin and streptomycin for spinal tuberculosis. The Spine Journal 4, 4-7
  27. Narbat KM, Orang F, Hashtjin SM, Goudarzi A (2006). Fabrication of porous hydroxyapatite-gelatin composite implans for bone tissue engineering. Iranian Biomed J. 10, 215-223
  28. Ning B, Zhao Y, Buza III JA, Li W, Wang W, Jia T (2017). Surgically-induced mouse models in the study of bone regeneration: Current models and future directions. Molecular Medicine Reports 15, 1017-1023
  29. Pagani F, Francucci CM, Moro L (2005). Markers of bone turnover: Biochemical and clinical perspectives J Endocrinol Invest 28, 8-13
  30. Raggatt LJ, Partridge NC (2010). Cellular and molecular mechanism of bone remodeling. Journal of Biological Chemistry 285, 25103-25108
  31. Ramirez-Fernandez MP, Calvo-Guirado JL, Delgado-Ruiz RA, Mate-Sanchez del Val JE, Gomez-Moreno G, Guardia J (2011). Experimental model of bone response to xenografts of bovine origin (Endone®): a radiological and histomorphometric study. Clin.Oral Impl.Res 22, 727-734
  32. Schlickewei WC, Laaff G, Andresen A, Klatte OT, Rueger Mj, Ruesing J, Epple M, Lehmann W (2015). Bone augmentation using a new injectable bone graft substitute by combining calcium phosphate and bisphosphonate as composite - an animal model. Journal of Orthopedic Surgery and Research 10, 116
  33. Seibel MJ (2000). Molecular markers of bone turnover: biochemical, technical and analytical aspects. International Osteoporosis Foundation and National Osteoporosis Foundation 6, S18-29
  34. Sihombing D, Nursiswati, Prawesti A (2012). Overview of foot care and sensory sensation of feet in patients with type 2 diabetes mellitus in the dm polyclinic hospital
  35. Silva RF, Sasso GRD, Cerri ES, Simoes MJ, Cerri PS (2015). Review article. Biology of bone tissue: structure, function, and factors that influence bone cells. BioMed Research International 2015, 1-17
  36. Sousa CP, Dias IR, Pena ML, Camassa JA, Lourenco PJ, Judas FM, Gomes ME, Reis RL (2015). Bone turnover markers for early detection of fracture healing disturbances. Anais da Academia Brasileira de Ciencias 87, 1049-1061

Most read articles by the same author(s)